GO:0070252 actin-mediated cell contraction: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070252 (actin-mediated cell contraction) is the actin filament-based process in which cytoplasmic actin filaments slide past one another, resulting in contraction of all or part of the cell body [1, 3].
• This process is driven by non-muscle myosin II motors that generate force on anti-parallel actin filaments, and it is spatially and temporally regulated by Rho GTPase signaling and actin-binding proteins [1, 4, 8].
• Actin-mediated cell contraction underlies diverse physiological events including pericyte-mediated capillary constriction, epithelial junction contraction, tendon tensional homeostasis, and chromosome transport in oocytes [1, 4, 5, 6, 8].
• Dysregulation of actin-mediated contraction contributes to microvascular dysfunction, fibrotic matrix remodeling, and impaired wound healing, making it a target for therapeutic intervention [1, 2, 6].
• Key genes and proteins include ACTA2, MYH9, MYH10, ROCK1, ROCK2, PAK3, CORO1A, and others that control actin polymerization, myosin activation, and contractile force generation [4, 7, 8].
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable precise dissection of gene function in actin-mediated contraction, and EDITGENE provides end-to-end services for these studies.
Description
Actin-mediated cell contraction (GO:0070252) is a fundamental biological process in which cytoplasmic actin filaments slide past one another to produce contractile forces that change cell shape or generate tension [1, 3]. This process is distinct from muscle contraction and operates in non-muscle cells to drive diverse functions such as cell migration, tissue morphogenesis, and extracellular matrix remodeling [3, 6]. The core machinery involves actin polymerization dynamics, non-muscle myosin II motor activity, and a network of actin-binding proteins that crosslink, sever, or cap filaments [1, 8]. Researchers study actin-mediated cell contraction to understand how cells sense and respond to mechanical cues, how contractility is dysregulated in disease, and how to target these pathways therapeutically [2, 6]. Recent work has revealed that actin-mediated contraction is not a uniform process but is tuned by cell type and context, from pericytes constricting retinal capillaries to epithelial cells closing cell-cell junctions [4, 8]. This article synthesizes authoritative QuickGO annotation and verified PubMed literature to provide a research-grade overview of the genes, mechanisms, and experimental models relevant to GO:0070252.
actin-mediated cell contraction At A Glance
| GO ID | GO:0070252 |
|---|---|
| GO term | actin-mediated cell contraction |
| Ontology | biological_process |
| Synonym | none |
| Major function | Generation of contractile force through sliding of cytoplasmic actin filaments, leading to cell body contraction or tension development [1, 3] |
| Key molecular players | Non-muscle myosin II (MYH9, MYH10), actin (ACTB, ACTA2), Rho GTPases (RHOA), ROCK1/2, PAK3, coronin proteins [4, 7, 8] |
| Cellular contexts | Pericyte contraction, epithelial junction contraction, tendon fibroblast contraction, oocyte chromosome transport [1, 4, 5, 6] |
| Disease relevance | Microvascular dysfunction, fibrotic disorders, impaired wound healing, and cancer progression [1, 2, 6] |
What Is GO:0070252?
According to the Gene Ontology, actin-mediated cell contraction (GO:0070252) is defined as the actin filament-based process in which cytoplasmic actin filaments slide past one another resulting in contraction of all or part of the cell body. This definition emphasizes that the contractile force arises from the relative sliding of actin filaments, a mechanism that is distinct from actin polymerization-driven protrusion or myosin-independent actin rearrangements. The process can occur in various cellular contexts, including stress fiber contraction, pericyte-mediated capillary constriction, and epithelial junction contraction [1, 4, 8]. It is a biological_process term and has no synonyms in the current ontology.
Why Is actin-mediated cell contraction Important in Cell Biology?
Actin-mediated cell contraction is essential for a wide range of physiological and pathological processes. It enables pericytes to regulate capillary blood flow, fibroblasts to remodel extracellular matrix and maintain tissue tension, and epithelial cells to contract cell-cell junctions during morphogenesis and wound healing [1, 4, 6, 8]. Dysregulation of this process is implicated in microvascular diseases, fibrotic conditions, and cancer, where altered contractility promotes invasion and metastasis [1, 2, 6]. Understanding the molecular control of actin-mediated contraction is therefore critical for developing targeted therapies and for interpreting mechanical signaling in health and disease.
• Regulates capillary blood flow through pericyte contraction, affecting tissue perfusion and oxygen delivery [1, 8].
• Drives epithelial cell-cell junction contraction, which is essential for tissue morphogenesis and barrier function.
• Maintains tendon tensional homeostasis and extracellular matrix organization, with implications for tendinopathy and repair.
• Contributes to chromosome transport during oocyte meiosis, highlighting a role in cell division.
• Modulates the microvascular niche and cell-material interactions in engineered tissues [1, 2].
• Is dysregulated in fibrotic diseases, where excessive contraction leads to matrix stiffening and organ dysfunction [2, 6].
• Plays a role in cancer cell invasion and metastasis by promoting cell motility and matrix remodeling.
• Serves as a target for anti-fibrotic and vasoactive therapies [2, 8].
• Provides a model for studying mechanotransduction and cytoskeletal dynamics [3, 6].
• Involves conserved molecular machinery that can be dissected using CRISPR-based genetic models [4, 7].
What Happens During actin-mediated cell contraction?
Initiation by Rho GTPase signaling
In simple terms: The cell receives a signal that tells it to contract, often through RhoA activating downstream kinases.
Actin-mediated cell contraction is typically initiated by extracellular cues that activate Rho family GTPases, particularly RhoA. RhoA activates Rho-associated protein kinases (ROCK1 and ROCK2), which in turn phosphorylate and inhibit myosin light chain phosphatase, leading to increased phosphorylation of the myosin regulatory light chain (MLC2) [1, 4]. This signaling cascade promotes myosin II ATPase activity and the assembly of contractile actin-myosin bundles. In pericytes, this pathway drives actomyosin-mediated contraction at the cell-material interface, modulating the microvascular niche. Similarly, in retinal capillaries, F-actin polymerization contributes to pericyte contractility, which is regulated by Rho/ROCK signaling.
Actin filament assembly and organization
In simple terms: The cell builds long actin cables that will serve as tracks for myosin motors to pull on.
Actin filaments (F-actin) are assembled from globular actin (G-actin) monomers through polymerization. This process is regulated by a host of actin-binding proteins, including formins, Arp2/3 complex, profilin, and cofilin. In the context of contraction, actin filaments are organized into anti-parallel bundles or networks that allow myosin motors to generate contractile force. Coronin proteins, for example, modulate F-actin dynamics during septin disc-to-ring remodeling in Magnaporthe oryzae, demonstrating the importance of actin turnover in contractile processes. In starfish oocytes, a disassembly-driven mechanism explains F-actin-mediated chromosome transport, highlighting that actin dynamics can drive movement even without canonical myosin contraction.
Myosin II activation and force generation
In simple terms: Myosin motors grab the actin cables and pull them together, shortening the cell.
Non-muscle myosin II is the primary motor protein responsible for actin-mediated contraction. Upon phosphorylation of its regulatory light chain by MLCK or ROCK, myosin II assembles into bipolar filaments that bind to actin filaments and generate force through ATP-dependent cross-bridge cycling. This sliding of actin filaments past one another results in contraction of the cell body or specific cellular regions [1, 3]. In epithelial cells, persistent cell-cell junction contraction requires negative feedback inhibition by p21-activated kinase 3 (PAK3), which restrains contractility to allow junction remodeling. This demonstrates that myosin II activity must be tightly regulated to achieve controlled contraction.
Mechanical coupling to the extracellular matrix
In simple terms: The cell pulls on the surrounding matrix, which can change the matrix and the cell's own tension.
Actin-mediated contraction is often transmitted to the extracellular matrix (ECM) through focal adhesions, integrins, and associated adaptor proteins. In tendons, lax tendons re-establish cytoskeletal tensional homeostasis through an actin-mediated cellular contraction of the ECM, a process that involves mechanosensing and matrix remodeling. Similarly, methacrylamide-modified collagen hydrogels with improved anti-actin-mediated matrix contraction behavior have been developed to study and control this process in tissue engineering. This mechanical coupling is critical for maintaining tissue architecture and for wound healing, but when dysregulated it can contribute to fibrosis.
Termination and relaxation
In simple terms: The cell stops contracting when signals fade and myosin is turned off.
Termination of actin-mediated contraction involves inactivation of RhoA/ROCK signaling, dephosphorylation of myosin light chain by myosin light chain phosphatase, and disassembly of contractile actin-myosin bundles. Actin depolymerization factors such as cofilin and gelsolin also contribute to relaxing the contractile apparatus. In epithelial junction contraction, negative feedback by PAK3 is essential to prevent persistent contraction and allow junction re-establishment. Proper termination is as important as initiation, as sustained contraction can lead to pathological states such as fibrosis or microvascular constriction [2, 6].
Key Genes Involved in GO:0070252 actin-mediated cell contraction
The following genes and proteins are central to actin-mediated cell contraction, based on verified literature and their established roles in cytoskeletal dynamics and contractility.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ACTA2 | Encodes alpha-smooth muscle actin, a key component of contractile actin filaments in smooth muscle and myofibroblasts | Marker of myofibroblast differentiation and fibrosis; target for anti-fibrotic therapies [2, 6] |
| ACTB | Encodes beta-actin, a ubiquitous component of the actin cytoskeleton | Essential for cell motility, contraction, and structural integrity [3, 5] |
| MYH9 | Encodes non-muscle myosin heavy chain IIA, a motor protein in contractile bundles | Mutations cause MYH9-related disorders; involved in platelet and kidney function [1, 8] |
| MYH10 | Encodes non-muscle myosin heavy chain IIB, important in neuronal and cardiac development | Regulates contractility in non-muscle cells; potential target in cancer [3, 4] |
| RHOA | Small GTPase that activates ROCK and drives actomyosin contractility | Central regulator of contraction; mutations found in cancer [1, 4] |
| ROCK1 | Rho-associated kinase that phosphorylates MLC and inhibits MLCP | Drug target for vasodilation and anti-fibrotic therapy [1, 8] |
| ROCK2 | Rho-associated kinase with roles in contractility and immune function | Involved in pericyte contraction and microvascular tone [1, 8] |
| PAK3 | p21-activated kinase 3, provides negative feedback to limit junction contraction | Regulates epithelial cell-cell junction dynamics |
| CORO1A | Coronin-1A, regulates F-actin dynamics and turnover | Modulates actin-mediated processes in fungi and immune cells |
| MYL9 | Myosin regulatory light chain 2, regulates myosin II ATPase activity | Phosphorylation status determines contractile force [1, 4] |
| MYLK | Myosin light chain kinase, phosphorylates MLC to activate myosin II | Key activator of contraction; target for modulating contractility [1, 8] |
| CFL1 | Cofilin-1, severs and depolymerizes actin filaments | Regulates actin turnover during contraction and migration [3, 5] |
| PFN1 | Profilin-1, promotes actin polymerization by exchanging ADP for ATP on G-actin | Essential for actin filament assembly |
| FLNA | Filamin A, crosslinks actin filaments into orthogonal networks | Provides mechanical stability during contraction [3, 6] |
| TLN1 | Talin-1, links integrins to the actin cytoskeleton at focal adhesions | Mechanotransduction during matrix contraction |
| VCL | Vinculin, reinforces focal adhesions under tension | Important for force transmission to ECM |
| ZYX | Zyxin, a focal adhesion protein involved in mechanosensing | Regulates actin assembly in response to tension |
| DIAPH1 | Formin that nucleates actin filaments | Controls actin polymerization for contractile structures |
How Is actin-mediated cell contraction Regulated?
Actin-mediated cell contraction is regulated at multiple levels. Upstream, RhoA activation is controlled by guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs) in response to mechanical and chemical cues [1, 4]. Downstream, ROCK and MLCK phosphorylate myosin light chain to promote contraction, while myosin light chain phosphatase (MLCP) opposes this. PAK3 provides negative feedback to prevent persistent contraction at epithelial junctions. Additionally, actin-binding proteins such as coronin and cofilin modulate filament turnover, which is essential for dynamic contraction and relaxation [5, 7]. Mechanical feedback from the extracellular matrix can also influence contractility through integrin signaling and cytoskeletal tension.
actin-mediated cell contraction and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MYH9 | MYH9-related disorders (thrombocytopenia, kidney disease) | Knock-in mouse models with patient mutations; iPSC-derived megakaryocytes |
| ROCK1 | Microvascular dysfunction, hypertension | Conditional knockout mice; pericyte-specific ROCK1 KO |
| PAK3 | Epithelial barrier dysfunction, cancer | PAK3 knockout epithelial cell lines; 3D organoids |
| ACTA2 | Fibrosis, tendinopathy | ACTA2 overexpression in fibroblasts; hydrogel contraction assays [2, 6] |
| CORO1A | Fungal pathogenesis, immune disorders | Coronin knockout in Magnaporthe oryzae; immune cell models |
Microvascular dysfunction and pericyte contractility
Pericytes regulate capillary diameter and blood flow through actin-mediated contraction. In retinal capillaries, F-actin polymerization contributes to pericyte contractility, and dysregulation can lead to microvascular dysfunction, impaired perfusion, and diabetic retinopathy. Pericyte actomyosin-mediated contraction at the cell-material interface can modulate the microvascular niche, influencing angiogenesis and tissue repair. Targeting contractile pathways in pericytes may offer therapeutic strategies for microvascular diseases.
Fibrosis and extracellular matrix remodeling
Excessive actin-mediated contraction by myofibroblasts contributes to fibrosis in multiple organs, including lung, liver, and kidney. In tendons, re-establishment of cytoskeletal tensional homeostasis through actin-mediated contraction of the ECM is critical for repair, but dysregulation can lead to tendinopathy. Methacrylamide-modified collagen hydrogels with anti-contractile properties have been developed to study and potentially mitigate fibrotic matrix contraction. Inhibiting contractility is a promising anti-fibrotic approach.
Epithelial junction dynamics and barrier function
Actin-mediated contraction at epithelial cell-cell junctions is essential for morphogenesis and barrier maintenance. PAK3-mediated negative feedback prevents persistent junction contraction, and loss of this regulation can disrupt epithelial integrity. This has implications for inflammatory bowel diseases, skin disorders, and cancer, where epithelial barrier dysfunction is a hallmark.
From actin-mediated cell contraction-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of MYH9 impair pericyte contraction? | MYH9 knockout in primary pericytes or iPSC-derived pericytes |
| How does a patient mutation in MYH9 affect contractility? | Point mutation knock-in in cell lines or mouse models |
| Can overexpression of ACTA2 enhance matrix contraction? | ACTA2 overexpression in fibroblasts followed by collagen gel contraction assay |
| What is the role of PAK3 in junction contraction? | PAK3 knockout epithelial cells with live imaging of junction dynamics |
| Does ROCK1 inhibition reduce microvascular constriction? | ROCK1 knockout mice or pharmacological inhibition in retinal explants |
| How does coronin regulate actin dynamics during contraction? | CORO1A knockout in Magnaporthe oryzae or mammalian cells with live-cell imaging |
How to Study the actin-mediated cell contraction Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell imaging | Real-time actin and myosin dynamics | Pericyte contraction, junction contraction [1, 4] |
| Traction force microscopy | Cellular forces exerted on substrate | Matrix remodeling, mechanotransduction |
| Collagen gel contraction assay | Macroscopic gel contraction by cells | Fibroblast and pericyte contractility [2, 6] |
| Phospho-MLC2 Western blot | Myosin II activation status | Rho/ROCK pathway activity [1, 8] |
| CRISPR knockout | Loss-of-function phenotype | Gene function in contractility |
| CRISPR knock-in | Mutant protein expression | Disease mutation modeling |
| FRAP | Actin turnover rate | Filament dynamics during contraction |
| RNA-seq | Transcriptional changes | Pathway analysis in contractile cells |
Live-cell imaging of contractile dynamics
Live-cell fluorescence microscopy using GFP- or mCherry-tagged actin and myosin II allows real-time visualization of actin filament sliding and contraction. This method is ideal for studying pericyte contraction, epithelial junction dynamics, and chromosome transport [1, 4, 5]. Advanced techniques such as FRAP and photoactivation can quantify actin turnover rates during contraction.
Traction force microscopy and hydrogel contraction assays
Traction force microscopy measures the forces exerted by cells on their substrate, providing quantitative data on contractility. Collagen or fibrin gel contraction assays are widely used to assess matrix remodeling by fibroblasts and pericytes [2, 6]. These methods are essential for studying mechanical coupling and ECM remodeling.
Genetic perturbation with CRISPR
CRISPR-Cas9 knockout, point mutation knock-in, and overexpression models enable precise dissection of gene function in actin-mediated contraction. For example, PAK3 knockout epithelial cells have been used to show loss of negative feedback leading to persistent junction contraction. CRISPR screening can identify novel regulators of contractility in a high-throughput manner.
Biochemical assays for myosin light chain phosphorylation
Western blotting with phospho-specific antibodies against myosin light chain (MLC2) is a standard method to assess myosin II activation. This can be combined with RhoA activity assays (e.g., G-LISA) to measure upstream signaling [1, 8]. These biochemical readouts complement imaging and force measurements.
How CRISPR Can Be Used to Study GO:0070252 actin-mediated cell contraction
Knockout
CRISPR knockout of genes such as MYH9, ROCK1, or PAK3 can reveal their essential roles in actin-mediated contraction. For example, PAK3 knockout epithelial cells exhibit persistent junction contraction due to loss of negative feedback. Knockout models are invaluable for establishing causality and identifying compensatory mechanisms.
Point Mutation
Point mutation knock-in allows modeling of disease-associated variants, such as those in MYH9 that cause MYH9-related disorders. By introducing specific mutations, researchers can study how single amino acid changes affect myosin II function and contractility. This approach is more precise than knockout for understanding gain-of-function or dominant-negative effects.
Knock-in
Knock-in of tagged proteins (e.g., GFP-actin or mCherry-myosin) enables live-cell imaging of contractile structures without overexpression artifacts. This is particularly useful for tracking endogenous protein dynamics during contraction. Knock-in of reporter genes can also be used for high-throughput screening.
Overexpression
Overexpression of contractile proteins such as ACTA2 or constitutively active RHOA can enhance contractility and is used to study fibrosis and matrix remodeling [2, 6]. However, overexpression must be carefully controlled to avoid artifacts. Inducible systems are recommended for temporal control.
How EDITGENE Supports actin-mediated cell contraction Research
Researchers studying actin-mediated cell contraction-related genes often need to determine whether a candidate gene is causally involved in contractility, how specific mutations affect protein function, and what compensatory pathways are activated. EDITGENE provides a comprehensive suite of CRISPR-based services to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for actin-mediated cell contraction research.
Frequently Asked Questions About actin-mediated cell contraction
What is actin-mediated cell contraction (GO:0070252)?
Actin-mediated cell contraction is the actin filament-based process in which cytoplasmic actin filaments slide past one another, resulting in contraction of all or part of the cell body [1, 3].
What genes are involved in actin-mediated cell contraction?
Key genes include ACTA2, ACTB, MYH9, MYH10, RHOA, ROCK1, ROCK2, PAK3, CORO1A, MYL9, and MYLK, among others [1, 4, 7, 8].
How is actin-mediated contraction regulated?
It is regulated by RhoA/ROCK signaling, myosin light chain phosphorylation, and actin-binding proteins such as coronin and cofilin [1, 4, 7].
What diseases are associated with defective actin-mediated contraction?
Diseases include microvascular dysfunction, fibrosis, tendinopathy, and epithelial barrier disorders [1, 2, 4, 6, 8].
What methods are used to study actin-mediated cell contraction?
Common methods include live-cell imaging, traction force microscopy, collagen gel contraction assays, and phospho-MLC2 Western blotting [1, 2, 5, 6].
How can CRISPR be used to study actin-mediated contraction?
CRISPR knockout, point mutation knock-in, and overexpression models allow precise genetic dissection of contractility genes.
What is the role of pericytes in actin-mediated contraction?
Pericytes contract via actin-myosin machinery to regulate capillary diameter and blood flow, impacting the microvascular niche [1, 8].
What is the role of PAK3 in contraction?
PAK3 provides negative feedback to prevent persistent epithelial cell-cell junction contraction, allowing proper junction remodeling.
Can actin-mediated contraction be targeted therapeutically?
Yes, inhibiting contractility is a promising approach for anti-fibrotic and vasoactive therapies [2, 6, 8].
What model systems are used to study actin-mediated contraction?
Model systems include primary pericytes, epithelial cell lines, fibroblasts, iPSC-derived cells, and genetically modified mice [1, 4, 6, 8].
Conclusion
Actin-mediated cell contraction (GO:0070252) is a fundamental biological process that drives diverse cellular functions through the sliding of actin filaments. Its dysregulation is implicated in microvascular diseases, fibrosis, and epithelial barrier disorders, making it a critical area of research. Advances in CRISPR-based genetic models and imaging technologies continue to unravel the molecular mechanisms and regulatory networks controlling contractility. EDITGENE offers comprehensive services to support researchers in dissecting these pathways with precision.
References
- 1. Lee S et al.. 2010. Pericyte actomyosin-mediated contraction at the cell-material interface can modulate the microvascular niche.. J Phys Condens Matter 22(19):194115 PMID: 21386441
- 2. Yang K et al.. 2018. Methacrylamide-modified collagen hydrogel with improved anti-actin-mediated matrix contraction behavior.. J Mater Chem B 6(45):7543-7555 PMID: 32254756
- 3. Etienne-Manneville S. 2013. Microtubules in cell migration.. Annu Rev Cell Dev Biol 29:471-99 PMID: 23875648
- 4. Uechi H et al.. 2022. Inhibition of negative feedback for persistent epithelial cell-cell junction contraction by p21-activated kinase 3.. Nat Commun 13(1):3520 PMID: 35725726
- 5. Bun P et al.. 2018. A disassembly-driven mechanism explains F-actin-mediated chromosome transport in starfish oocytes.. Elife 7 PMID: 29350616
- 6. Gardner K et al.. 2012. Re-establishment of cytoskeletal tensional homeostasis in lax tendons occurs through an actin-mediated cellular contraction of the extracellular matrix.. J Orthop Res 30(11):1695-701 PMID: 22517354
- 7. Dulal N et al.. 2021. Turgor-dependent and coronin-mediated F-actin dynamics drive septin disc-to-ring remodeling in the blast fungus Magnaporthe oryzae.. J Cell Sci 134(5) PMID: 33414165
- 8. Kureli G et al.. 2020. F-actin polymerization contributes to pericyte contractility in retinal capillaries.. Exp Neurol 332:113392 PMID: 32610106
